Vopratelimab (Anti-ICOS / CD278)

Synonyms: JTX 2011

Vopratelimab (Anti-ICOS / CD278) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that binds specifically to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab exhibits antitumor immune response. MW: 145.5 KD.

Vopratelimab (Anti-ICOS / CD278)

Purity & Quality Control

Batch: A246301 Purity: 99% Protein concentration: 7.13mg/ml Endotoxin Level: <1EU/mg
99

Biological Activity

Description Vopratelimab (Anti-ICOS / CD278) is a humanized immunoglobulin G1-kappa agonist monoclonal antibody that binds specifically to the Inducible CO-Stimulator of T cells (ICOS). Vopratelimab exhibits antitumor immune response. MW: 145.5 KD.

Product Details

CAS No.  2039148-04-2
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vopratelimab (Anti-ICOS / CD278) | Vopratelimab (Anti-ICOS / CD278) supplier | purchase Vopratelimab (Anti-ICOS / CD278) | Vopratelimab (Anti-ICOS / CD278) cost | Vopratelimab (Anti-ICOS / CD278) manufacturer | order Vopratelimab (Anti-ICOS / CD278) | Vopratelimab (Anti-ICOS / CD278) distributor